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698Objective: We previously developed a native heart load control system for a continuous-flow left ventricular
assist device and demonstrated that the rotational speed synchronized with the cardiac cycle can alter left
ventricular preload and myocardial oxygen consumption. In the present study, we assessed this system in a
conscious goat model of chronic heart failure.
Methods: Chronic heart failure was induced by coronary microsphere embolization of the left ascending artery
and subsequent rapid ventricular pacing in 6 goats. After 4 to 6 weeks of rapid pacing, the goats showed a
decreased ejection fraction (from 89.7%  3.1% to 53.3%  5.4%) measured during sinus rhythm. The assist
device was implanted by way of a left thoracotomy, and we examined the effects of the continuous, co-pulse,
and counterpulse mode on the end-diastolic volume and stroke work, determined from the left ventricular
pressure–volume loops.
Results: Significant decreases were found in the end-diastolic volume and stroke work in the counterpulse mode
relative to the values observed with 0% bypass (63.4%  15.2% and 39.1%  18.2%, respectively; P<.01).
Furthermore, both increased in the co-pulse mode (82.1%  17.6% and 68.3%  22.2%; P<.01) compared
with those in the continuous mode (69.6%  15.4% and 54.6%  21.6%) with 100% bypass.
Conclusions: The system offers the possibility to control the left ventricular load by changing the rotational
speed of a continuous-flow assist device in synchronization with the cardiac cycle. This system should provide
the most favorable left ventricular loading conditions for recovery of the native heart. (J Thorac Cardiovasc Surg
2014;148:698-704)Since continuous-flow left ventricular (LV) assist devices
(LVADs) were first approved, the number of patients treated
with continuous-flow LVADs has been increasing owing to
the improved prognosis and fewer complications.1,2 Most
patients with an implanted LVAD have been on the
waiting list for heart transplantation and, thus, have had
the LVAD implanted as a bridge to transplantation.
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The Journal of Thoracic and Cardiovascular Surgand this shortage has been especially severe in Japan.3 In
some cases, myocardial recovery will allow LVAD explan-
tation, and this has been termed ‘‘bridge to recovery’’
(BTR).4,5 Because of the extreme shortage of donor
hearts, it is important to investigate methods to increase
the success rate of BTR. Unloading the left ventricle by
an LVAD has been reported to lead to improvement in
cardiac function.4 In contrast, it has also been reported
that excess unloading leads to cardiac atrophy.6 We have
presumed that a favorable work load is required for cardiac
recovery and that the workload should be adapted to the
patient’s condition.
We have previously reported the development of novel
pump control system for a continuous-flow LVAD (EVA-
HEART; Sun Medical Technology Research Institute,
Nagano, Japan).7 This system was termed the native heart
load control system (NHLCS) and was shown to control
the hemodynamic parameters such as pulsatility,8 myocar-
dial perfusion,9 and LV end-diastolic volume (LVEDV)10
by changing the rotational speed (RS) in synchronization
with the cardiac cycle.
To evaluate the effects of the NHLCS in detail, it
is important to evaluate its long-term performance in
a closed-chest animal model with impaired cardiacery c August 2014
Abbreviations and Acronyms
%LVEDV ¼ LVEDV percentage of the 0% bypass
condition
%SW ¼ SW percentage of the 0% bypass
condition
BTR ¼ bridge to recovery
EF ¼ ejection fraction
LV ¼ left ventricular
LVAD ¼ LV assist device
LVEDV ¼ LV end-diastolic volume
NHLCS ¼ native heart load control system
PV ¼ pressure–volume
PF ¼ pump flow
RS ¼ rotational speed
SW ¼ stroke work
Arakawa et al Evolving Technology/Basic Sciencefunction.11 In the present study, we aimed to establish a
chronic heart failure model and assess the effect of our
EVAHEART on hemodynamics in a conscious animal
model of chronic heart failure.E
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Animals
Six adult goats weighing 56.7  5.1 kg were maintained in accordance
with the guidelines of the Committee on Animal Studies at the National Ce-
rebral and Cardiovascular Center. The National Cerebral and Cardiovascu-
lar Center Animal Investigation Committee approved the present study.
Chronic Heart Failure Model
In the present study, we created chronic heart failure using coronary ar-
tery embolization through the left anterior descending coronary artery, as
described previously.10,12 In brief, a 4F Amplatz catheter (Create Medic
Co, Ltd, Yokohama, Japan) was inserted through a 4F-long sheath into
the left carotid artery toward the left anterior descending coronary artery
under fluoroscopic guidance, and 50-mm microspheres were injected
(4500/kg). We also placed a permanent pacing lead (Tendril STS, 58 cm,
St Jude Medical, Inc, St Paul, Minn) into the right ventricle through the
right jugular vein and connected it to a pacemaker (TNT-002N, Taisho
Biomed Instruments Co, Ltd, Osaka, Japan) that was implanted
subcutaneously in the right shoulder. In addition, we placed an arterial
pressure line through the right carotid artery. Four days after
embolization, rapid ventricular pacing at 200 beats/min was initiated and
continued for 4 to 6 weeks. To control the impairment of cardiac
function, we measured the ejection fraction (EF) during sinus rhythm
using transthoracic echocardiography (Vivid E9, GE Healthcare, Horten,
Norway). The duration of pacing was continued until the EF was
reduced to 50% of baseline.
LVAD Implantation
After 48 hours of fasting, all the goats were sedated with an intramus-
cular injection of ketamine (10 mg/kg). General anesthesia was induced
and maintained by inhalation of isoflurane (1%-3% in oxygen). The goats
were fixed in the right recumbent position, intubated, and mechanically
ventilated. A left thoracotomy along the fifth costal bone was performed,
and pressure lines for aortic pressure and central venous pressure measure-
ment were placed into the left intrathoracic artery and vein, respectively.The Journal of Thoracic and CaThis was followed by attachment of an electromagnetic flow meter
(EMF-1000, 17-20 mm in diameter, Nihon Kohden, Tokyo, Japan) around
the ascending aorta. After heparinization (200 U/kg), the centrifugal LVAD
(EVAHEART; Sun Medical Technology Research Corp, Nagano, Japan)
was installed by punching out the LVapex with a 16-mm puncher, inserting
the inflow cannula into the left ventricle and suturing the outflow conduit
(16-mm J Graft SHIELD NEO, Japan Lifeline, Tokyo, Japan) into the
descending aorta. We used an ultrasonic flow meter (16 mm; TS420,
Transonic Systems, Ithaca, NY) to measure the LVAD pump flow (PF).
After establishing the pump circuit, we attached 2 ultrasonic crystals
(Sonometrics, Ontario, Canada) in the anterior and posterior endocardium
to measure the LV diameter in the short axis. This diameter was then used
to calculate the LV volume using a single-axis sphere. In addition, a LV
pressure line was inserted from the anterior wall.
Study Protocol and LVAD Control
Two days after LVAD implantation, when the goats had recovered from
the acute effects of the operation, we tested 3 drive modes using our previ-
ously described NHLCS.10,12 With this controller, we were able to change
the RS of the EVAHEART for a specific period after the occurrence of an R
wave to synchronize it with the cardiac cycles. We defined the systolic
phase as 30% of the RR interval, and the diastolic phase as 65% of the
RR interval. These parameters were evaluated twice in each goat using
the following 3 conditions: (1) the continuous mode (constant RS
without the use of the novel controller); (2) the co-pulse mode (increased
RS in the systolic phase and decreased RS in the diastolic phase using
the novel controller); and (3) the counterpulse mode (decreased RS in
the systolic phase and increased RS in the diastolic phase with the novel
controller). In these drive modes, we set the RS from 1500 to 3000 rpm
to achieve a proper bypass rate. In addition, the difference between the
systolic and diastolic phase was set to approximately 500 to 1000 rpm.
Statistical Analysis
The bypass rate was calculated by dividing the pump flow (PF) rate by
the sum of the PF and ascending aortic flow rates. We defined full bypass as
a bypass rate of 100%. We tested the 3 drive modes at bypass rates of 50%,
75%, and 100% for 10 minutes. Next, we performed the 3 modes at a
bypass rate of 100% for 12 hours to evaluate the effects of the system
for a prolonged period. To evaluate appropriate support, we checked the
actual RS and speed changes. The bypass rate was calculated in real time
and displayed on a monitor.
The hemodynamic data were recorded using Labchart, version 7,
software (ADInstruments, Castle Hill, Australia). The implanted ultrasonic
crystals provided the LV chamber diameter in the short axis, and this was
used to estimate the LV volume from a single-axis spherical model. LV
pressure–volume (PV) loops were drawn for each mode, and the stroke
work (SW) was calculated from the area inside the PV loop using
CardioSOFT (Sonometrics). The LV end-diastolic pressure and LVEDV
were determined from the PV loops. For the comparison between each
control mode, the LVEDV and SW are expressed as percentages of the
0% bypass condition (%LVEDVand%SW, respectively).
All numeric data are shown as the average  standard deviation. The
data between pre-embolization and pre-LVAD implantation were
compared using a paired Student’s t test. Other comparisons between the
groups were performed using repeated measures analysis of variance
followed by Tukey’s multiple comparison tests. All analyses were
performed using the Statistical Package for Social Sciences, version 19
(SPSS Inc, Chicago, Ill).Effect of LVAD on Hemolysis and Myocardial
Histologic Findings
To evaluate hemolysis, we measured free hemoglobin before and after
the 3 modes had been applied for 12 hours in 1 of 6 goats. In addition, anrdiovascular Surgery c Volume 148, Number 2 699
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a previous report.13 Fresh bovine blood (600 g) was used, and the blood
temperature was maintained at 37  1C. Blood samples were collected
for measurement of plasma free hemoglobin just after the pump’s condi-
tion had become stable and at 30-minute intervals for 4 hours. We drove
the EVAHEART in the co-pulse mode at a pulse rate of 60 beats/min.
The RS was set 3000 rpm for high and 1000 rpm for the difference. These
settings were representative of the most severe condition of the novel
mode. The mean head pressure was set at 100 mm Hg and the PF at
5.0 L/min for the continuous and co-pulse modes both. These settings
were the same as those in a previous report.13 We used the normalized
index of hemolysis to evaluate hemolysis: normalized index of hemolysis
(g/100 L) ¼ D plasma free hemoglobin (g/L) 3 priming volume
(L)3 ([(100 hematocrit)/100]3 [100/PF in L/min3 time in minutes]).
We performed biopsy from the apex during LVAD implantation and nec-
ropsy when the goats had been killed 1 month after LVAD implantation to
evaluate the pathologic changes due to LVAD implantation. The samples
were fixed immediately in 10% neutral-buffered formalin and embedded
in paraffin wax. Thin sections were cut and stained with hematoxylin and
eosin.
RESULTS
Chronic Heart Failure Model With LVAD Support
We performed rapid pacing for 31.4  5.7 days. The EF,
measured by echocardiography, decreased from 89.7% 
3.1% at the pre-embolization baseline to 53.3%  5.4%
just before LVAD implantation (P<.01).
Hemodynamic and LVAD Data
Figure 1 shows sample waveforms from the electrocar-
diogram, aortic pressure, detected R waves, LV pressure,
PF, native flow, and RS. Important differences were present
among the PF waveforms with the 3 different modes. The
maximum PF increased after an increase in the RS in the
systolic phase in the co-pulse mode compared with that in
the continuous mode. In contrast, the PF in the diastolic
phase increased in the counterpulse mode compared with
that in the continuous mode. The hemodynamic data in
each mode are listed in Table 1. The heart rate, central
venous pressure, aortic pressure, total flow, and bypass
rate were not significantly different among the 3 modes.
The average RS in the counterpulse mode decreased
significantly compared with those in the continuous and
co-pulse modes at each bypass rate.
PV Loops
Figure 2 shows 1 sample set of PV loops for each mode.
The horizontal axis shows the LV volume and the vertical
axis the LV pressure. The lower right points indicate the
end-diastolic points, and the area inside the loop indicates
the SW. The LVEDV (preload) increased in the co-pulse
mode and decreased in the counterpulse mode compared
with that in the continuous mode.
Figure 3 shows the average LVEDVs measured in the 6
goats. The%LVEDVand%SW were decreased according
to the decrease in the bypass rate in the continuous mode.
The %LVEDV was significantly increased in the co-pulse700 The Journal of Thoracic and Cardiovascular Surgmode compared with that in the continuous mode at the
75% bypass rate. SW was also increased in the co-pulse
mode compared with that in the continuous mode at the
75% and 100% bypass rates. Furthermore, the %LVEDV
was significantly increased in the co-pulse mode compared
with that in the counterpulse mode at each bypass rate. The
%SW was also increased in the co-pulse mode compared
with that in the counterpulse mode at each bypass rate. In
the counterpulse mode, the%LVEDVand%SWwere rela-
tively lower than those in the continuous mode, although the
differences were not significant.
Appropriate Support
To check for appropriate support, we evaluated 7688 
400 beats/h, on average. Appropriate support was achieved
for>90% of cardiac beats in 1 hour. The most frequent
cause of inappropriate support was a failure to sense the
R wave by the controller (4.4%).
Effect of LVAD on Hemolysis and Myocardial
Histologic Findings
The free hemoglobin in vivo showed a slight elevation af-
ter each mode of pumping. The hemoglobin values before
and after each mode were 2.7 and 5.2 mg/dL in the contin-
uous mode, 5.2 to 5.9 mg/dL in the co-pulse mode, and 4.2
and 6.4 mg/dL in the counterpulse mode, respectively.
Regarding the in vitro hemolysis test, plasma free hemoglo-
bin was slightly increased in the samples collected after the
pump had run for 4 hours in the continuous and co-pulse
modes both. The hemoglobin values just after the pump’s
condition had become stable and after 4 hours of pumping
in each mode were 0.6 and 3.4 mg/dL in the continuous
mode, 3.4 to 5.0 mg/dL in the co-pulse mode, and 4.2
mg/dL and 6.4 mg/dL in the counterpulse mode, respec-
tively. However, the normalized index of hemolysis was
not different between the continuous and co-pulse modes
(0.000944 vs 0.000843, respectively). In addition, we found
focal myocardial fibrosis (Figure 4, A and C), but this was
not affected by LVAD implantation. No remarkable change
was found in the cardiomyocyte size after support with this
system, although the mode was switched in each goat
(Figure 4, B and D).
DISCUSSION
For the first time, we have reported an evaluation of the
effects of the NHLCS in a chronic heart failure model. To
our knowledge, several reports have evaluated the effects
of a control system with electrocardiogram-synchronized
RS changes.8,10,12,14-16 However, our study is the first to
evaluate this system in a conscious animal model of
chronic heart failure. Our results have indicated the
feasibility of the long-term use of this system. Thus, our
results provide information regarding what might be ex-
pected when this system is used in the clinical setting.ery c August 2014
FIGURE 1. Sample pressure and flow waveforms at full bypass in each mode. In the co-pulse mode, the pump flow increased in the systolic phase, which
was followed by an increase in the rotational speed (RS). In contrast, in the counterpulse mode, the pump flow had increased in the diastolic phase, followed
by an increase in the RS compared with the continuous mode.
Arakawa et al Evolving Technology/Basic ScienceFurthermore, the results showed no adverse events such as
an increase of hemolysis or myocardial overload, and the
system provided reliable support.
According to a previous report, unloading of the left
ventricle is a factor that promotes cardiac recovery.4 How-
ever, we have assumed that unloading is not the only factor
that promotes cardiac functional recovery. Excessive
unloading of the left ventricle by an LVAD could lead
to cardiac disuse atrophy.6 Furthermore, clenbuterol, a
b2-receptor agonist, has been reported to increase the
success rate of BTR.17,18 From these findings, a favorable
cardiac workload for the native heart according to the
patient’s condition should be considered to achieve
optimal cardiac recovery. Because the co-pulse mode canTABLE 1. Hemodynamic data
Variable
50% Bypass rate 75% B
Continuous
mode
Co-pulse
mode
Counterpulse
mode
Continuous
mode
Co-
m
HR (beats/
min)
126.0  16.4 128.7  16.5 126.0  15.7 128.5  16.8 128.8 
Mean CVP
(mm Hg)
3.2  2.9 3.0  2.8 2.1  3.2 3.4  3.4 2.8 
Mean AoP
(mm Hg)
87.2  21.3 83.7  19.1 87.0  20.6 87.8  18.2 86.4 
PF (L/min) 2.0  0.6*,y 2.1  0.6*,y 2.0  0.6*,y 3.3  1.2y,z 3.2 
Total flow
(L/min)
3.9  1.3 3.9  1.3 3.9  1.3 4.3  1.5 4.3 
RS (rpm) 1648  116*,y 1721  295*,y 1563  158*,y 1890  134y,z,x 1852 
Bypass
rate (%)
51.2  4.3*,y 53.3  4.5*,y 52.6  4.0*,y 75.0  3.2y 76.3 
LVEDP
(mm Hg)
14.7  9.3 15.5  9.9 11.8  9.5 9.3  7.9 15.3 
HR, Heart rate; CVP, central venous pressure; AoP, aortic pressure; PF, pump flow; RS, ro
with the same mode. yCompared with 100% with the same mode. zCompared with 50% w
mode. {Compared with co-pulse mode.
The Journal of Thoracic and Caprovide active LV load management, the native heart can
contract by itself in this mode; therefore, it acts as the car-
diac training mode. The counterpulse mode can decrease
the LV load. In the counterpulse mode, the native heart
can rest, but systemic assistance is maintained. Therefore,
it can be used as a cardiac resting mode.
Umeki and colleagues10,12 demonstrated the ability of the
newly developed NHLCS to control the LVEDV and
myocardial oxygen consumption. These parameters were
increased in the co-pulse mode and decreased in the coun-
terpulse mode in those studies. Our results were largely
similar to theirs, although several differences were present.
First, we required a higher RS speed to achieve the target
bypass rate, because the mean blood pressure was greaterypass rate 100% Bypass rate
pulse
ode
Counterpulse
mode
Continuous
mode
Co-pulse
mode
Counterpulse
mode
19.7 127.6  18.1 126.0  15.6 128.7  16.5 126.8  16.4
4.2 3.8  4.3 2.5  3.2 1.6  3.3 3.3  3.9
20.3 92.0  21.0 94.4  20.0 91.2  19.9 95.0  20.2
1.0y,z 3.2  0.8y,z 4.3  1.1*,z 4.3  1.4*,z 4.2  1.0*,z
1.3 4.2  1.2 4.1  1.2 4.0  1.4 4.0  1.3
177y,z,x 1637  164y,z,jj,{ 2046  102*,z,x 1941  276*,z 1783  204*,z,{
2.7y,z 75.5  5.6y,z 100.0  4y,z 101.6  9.3*,z 96.9  8.7*,z
9.1 7.6  8.6 7.7  7.7 10.9  8.5 7.2  7.8
tational speed; LVEDP, left ventricular end-diastolic pressure. *Compared with 75%
ith the same mode. xCompared with counterpulse mode. jjCompared with continuous
rdiovascular Surgery c Volume 148, Number 2 701
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FIGURE 2. Pressure–volume loops at full bypass at baseline and for each mode. The end-diastolic point is shown by the black dot. In the co-pulse mode, the
end-diastolic points had shifted rightward compared with those in the continuous mode and had a value that was similar to baseline. In the counterpulse mode,
the end-diastolic points had shifted leftward and decreased comparedwith those in the continuousmode. Furthermore, the pressure–volume loop areawas increased
in theco-pulsemodeanddecreased in thecounterpulsemodecomparedwith that in thecontinuousmode.LVV, Left ventricularvolume;LVP, left ventricularpressure.
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we simply compared the effects of the different NHLCS
modes in the present study, because we were not able toFIGURE 3. The left ventricular end-diastolic volume (LVEDV) and stroke wo
bypass (100%). A trend was seen for the percentage of LVEDV in the co-pulse m
mode to decrease compared with that in the continuousmode. In addition, a simi
at each bypass rate and for the SW in the counterpulse mode to decrease comp
702 The Journal of Thoracic and Cardiovascular Surgclamp the LVAD circuit to hold the PF constant. Third,
we have demonstrated the effects of NHLCS in a chronic
heart failure model.rk (SW) are shown relative to the baseline, which was obtained under 0%
ode to increase at each bypass rate and for the LVEDV in the counterpulse
lar trend was seen for the percentage of SW in the co-pulse mode to increase
ared with that in the continuous mode. *,þP<.05; þþ,**P<.01.
ery c August 2014
FIGURE 4. Myocardial hematoxylin and eosin stain, (A and B) before, and (C and D) after left ventricular assist device implantation. Scale bars represent
(A and C) 500 mm and (B and D) 50 mm.
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synchronized RS control systems have beneficial effects
on cardiac load and hemodynamics. Significant controversy
has resulted regarding the differences between pulsatile and
nonpulsatile hemodynamics.19-23 Our system can generate
artificial pulsatility, in addition to the beneficial effects on
the cardiac workload.8 In addition, Kishimoto and col-
leagues24 reported that speed modulation can open
the aortic valve and might prevent aortic insufficiency.
Furthermore, Ando and colleagues25,26 reported that to
prevent backward flow, it is possible to increase the RS in
the diastolic phase and thus create a circuit clamp
condition resembling the ‘‘off-test mode.’’ We believe
that the NHLCS has the potential to improve the
success rate of cardiac recovery and allow more options
in the treatment of patients with an implanted rotary
blood pump.
Our study had several limitations. We used an animal
model of LV dysfunction that showed decreased contrac-
tility. However, the EF did not actually decrease to a level
that would warrant LVAD implantation in a clinical setting.
To compare the effect of different NHLCS operatingmodes,
it would be better to use an impaired cardiac function
model.10 In addition, we did not show actual myocardial
recovery, because we tested the NHLCS for 12 hours,
which was not long enough to evaluate recovery. However,
we have developed a program for the NHLCS that
will make it suitable for long-term use. We are currently
investigating the actual long-term effects of this system
on cardiac recovery and adverse events in a chronic heart
failure model.The Journal of Thoracic and CaCONCLUSIONS
We have shown that the NHLCS can actively control the
LV load in a chronic heart failure model. The NHLCS can
provide a favorable LV load in each phase of cardiac
recovery, contributing to an increase in the success rate of
BTR therapy.
The authors are grateful to Dr Daisuke Ogawa in the Sun Med-
ical Technology Research Corporation for creating the programs.References
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